CIK 0001022899 · Non-accelerated filer<br>Smaller reporting company
Protagenic Therapeutics, Inc.new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061390025
- Phone
- (212) 994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- UPLOAD Other SEC-generated Letter
- 10-12G Other 10-12G
- EFFECT Other Notice of Effectiveness
- 15-12G Other 15-12G
- POS AM Other Post-effective Amendment for Registration Statement
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- 8-K Event Other events
- 8-K Event Executive or director change
- 8-K Event Other events
- 8-K Event Acquisition or sale completed
- 8-K Event Impairment
- 8-K Event Other events
- 8-K Event Material agreement · Agreement ended · Other events
- 8-K Event Acquisition or sale completed · Other events
- 8-K Event Debt accelerated
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 25 Other Notification of Removal from Listing
Page 18 of 36 · 707 filings